🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
Allogeneic stem cell transplant is used to treat a variety of blood cancers...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2019-04-11
Trial ID
NCT03689894
A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosi...
Status
Completed
Location
Site Reference ID/Investigator #047
Start Date
2013-03
Trial ID
NCT01722487
Treatments Being Tested
First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Status
Recruiting
Location
University Hospital of Mainz
Start Date
2024-02-15
Trial ID
NCT06482684
This randomized phase III trial studies ibrutinib to see how well it works ...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-10-12
Trial ID
NCT02443077
The purpose of this study is to assess the efficacy of ruxolitinib against ...
Status
Completed
Location
Incyte Investigative Site
Start Date
2017-06-29
Trial ID
NCT03112603
This is a prospective phase II open-label trial, stratifying patients equal...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2015-10-09
Trial ID
NCT02575300
Treatments Being Tested
This phase II trial studies how well ibrutinib and rituximab given together...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-05-01
Trial ID
NCT03710772
Venetoclax and ibrutinib have complementary activity in clearing the diseas...
Status
Terminated
Location
Kantonsspital Aarau
Start Date
2019-03-11
Trial ID
NCT03708003
Treatments Being Tested
The purpose of this study is to confirm that the pharmacokinetics of ibruti...
Status
Terminated
Location
Multiple Locations
Start Date
2016-07-01
Trial ID
NCT02703272
Treatments Being Tested